baber/WOPTO huggingface dataset:
Patent NZ-211648-A (NZ)
Title: Thiadiazines and pharmaceutical compositions
Inventor: JONES S D
IPC: C07D285/18
Filed: 1985-04-01
Abstract: Novel 1,2,4-thiadiazines of the formula    <IMAGE>  I  wherein R3 is selected from the group consisting of hydrogen, -OH, -CF3, alkyl, alkoxy and alkylthio of 1 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms optionally substituted with alkyl of 1 to 6 carbon atoms and   <IMAGE>  R1 and R2 are individually selected from the group consisting of hydrogen and alkyl of 1 to 3 carbon atoms or taken together with the nitrogen to which they are attached form a saturated heterocycle of 4 to 8 carbon atoms optionally containing a heteroatom of the group consisting of -O-, -S- and   <IMAGE>  and R' is hydrogen or alkyl of 1 to 3 carbon atoms, R5 is   <IMAGE>  R4 is selected from the group consisting of hydrogen, halogen and alkyl and alkoxy of 1 to 3 carbon atoms, R6 is selected from the group consisting of hydrogen, halogen and alkyl of 1 to 3 carbon atoms with the proviso that R6 may represent halogen only when R3 is hydrogen, -OH, alkyl and alkoxy of 1 to 6 carbon atoms or cycloalkyl of 3 to 6 carbon atoms optionally substituted with alkyl of 1 to 6 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having a remarkable anxiolytic activity and novel intermediates.
Patent NZ-219919-A (NZ)
Title: Vacuum packaged mussels heated to be cooked or precooked
Inventor: BOYLAN D
IPC: B65B55/00
Filed: 1987-04-08
Abstract: A process for packing and treating mussels or other bivalve seafood comprises arranging the bivalves (10) in at least one layer in an envelope (11) which is adapted to maintain the shells (13, 14,) of the bivalves in a substantially closed condition, and thereafter heating the bivalves and envelope for sufficient time and at sufficient temperature to at least partially cook the bivalves to induce the bivalve meat to curl up within the shells. Preferably the envelope (11) is of flexible material and the bivalves are vacuum packed within the envelope such that the envelope is drawn tightly around the bivalves. Further, the envelope is preferably of a heat-shrinkable plastics material, the envelope material being heat shrunk during vacuum packing.
Patent NZ-235504-A (NZ)
Title: Baghouse with dirty filter bags removed and clean bags installed while baghouse is operational
Inventor: PRICE THOMAS LESLIE
IPC: B01D46/02
Filed: 1990-09-28
Abstract: A baghouse chamber divided into an inlet (27) for receiving a gas stream containing particulates, an outlet (28) for exiting said gas stream after filtering, a main chamber (12) and an auxiliary chamber (14, 16). At least one filter bag (22) is housed within the main chamber for filtering said gas stream. The filter bag has an extension portion (25) extending through a connection (26) into the baghouse chamber. The connection (26) prevents particulate from bypassing the outlet (28) of the baghouse chamber and allows for pulling a replacement filter bag attached to the extension portion into the main chamber. A removal means (38, 40) is attached to the baghouse for transporting the at least one operable filter bag (22) to the auxiliary chamber and for pulling the replacement filter bag into the main chamber.
Patent NZ-240762-A (NZ)
Title: Oral solution comprising a cyclosporin, a poe-pop block copolymer and propylene glycol
Inventor: ORBAN ERNO
IPC: A61K38/13
Filed: 1991-11-27
Abstract: The invention relates to a pharmaceutical composition for oral administration containing cyclosporin A and/or cyclosporin G as active ingredient, which possess advantageous absorption characteristics, and to a process for preparing this composition. The composition according to the invention comprises 1 part by mass of one or more cyclosporin(s) dissolved in 4 to 50 parts by volume of propylene glycol, 0 to 25 parts by volume of ethanol and 0.0 to 5 parts by mass of a polyoxyethylene/polyoxypropylene block polymer in homogenized state. Based on examinations carried out at 100 DEG  C., the stability of solutions prepared according to the invention does not differ from that of the commercially available Sandimmun oral solution.
Patent NZ-240797-A (NZ)
Title: Collating apparatus for high speed packaging of flat articles
Inventor: VERNON GEOFFREY WILLIAM
IPC: B65G60/00
Filed: 1991-11-29
Abstract: Collating apparatus for collecting and handling stacks of generally flat articles (T) comprises a chute (40) in which the successive stacks are collected. Each completed stack is expelled from the chute by pusher means (52) into a carriage (58) of transfer device (54). The transfer device has mounted on a rotary axis (56) inclined at 45 DEG . Each rotation of the transfer device brings one carriage to a vertical position to receive the completed stack from the chute and brings the stack previously loaded into the other carriage to a horizontal position over a carton (C) into which the stack is to be deposited. <IMAGE>
Patent NZ-243530-A (NZ)
Title: Manganese complexes of n-containing macrocyclic ligands, the n-containing compounds and pharmaceutical compositions
Inventor: ASTON KARL WILLIAM
IPC: C07D259/00
Filed: 1992-07-13
Abstract: The present invention is directed to low molecular weight mimics of superoxide dismutase (SOD) represented by the formula: <CHEM> wherein R, R min , R1, R min 1, R2, R min 2, R3, R min 3, R4, R min 4, R5, R min 5, R6, R min 6, R7, R min 7, R8, R min 8, R9, and R min 9 and X, Y, Z and n are as defined herein, useful as therapeutic agents for inflammatory disease states and disorders, ischemic/reperfusion injury, stroke, atherosclerosis, hypertension and all other conditions of oxidant-induced tissue damage or injury.
Patent NZ-244907-A (NZ)
Title: Vibration friction welding of flexible thermoplastic straps with dynamically balanced upper strap-engaging jaw
Inventor: CHEUNG NELSON
IPC: B29L29/00
Filed: 1992-10-28
Abstract: A movable strap-engaging member (20) is provided for being connected at a first pivot axis to a vibrator arm (30) for accommodating pivot movement of the vibrator arm (30) about the pivot axis while the movable strap-engaging member (20) is pressing a first length (U) of flexible thermoplastic strap against a second length (L) such strap in an elongate strap-receiving path. The movable strap-engaging member (20) is reciprocated generally transversely of the path to effect a friction-fusion weld of the strap lengths (U, L) . The movable strap-engaging member (20) has a configuration in which first and second centers of mass (M1, M2) are spaced apart on a line (75) that passes through the pivot axis and that is oriented generally perpendicular to the path. The product of the square of the distance (r1) along the line (75) between the pivot axis and the first center of mass (M1) is substantially equal to the product of the square of the distance (r2) along the line (75) between the pivot axis and the second center of mass (M2). <IMAGE>
Patent NZ-266541-A (NZ)
Title: Imidazole derivatives, intermediate compounds and pharmaceutical compositions
Inventor: STEVENS RODNEY W
IPC: A61K31/4178
Filed: 1994-05-25
Abstract: PCT No. PCT/JP94/00836 Sec. 371 Date May 6, 1996 Sec. 102(e) Date May 6, 1996 PCT Filed May 25, 1994 PCT Pub. No. WO94/29299 PCT Pub. Date Dec. 22, 1994Certain novel imidazole derivatives having the ability to inhibit the lipoxygenase enzyme and having formula (I), wherein Y is hydrogen, C1-C8 alkyl, halosubstituted C1-C4 alkyl, phenyl, substituted phenyl, C7-C14 phenylalkyl, C7-C14 (substituted phenyl)alkyl, pyridyl, substituted pyridyl, C6-C13 pyridylalkyl or C6-C13 (substituted pyridyl)alkyl, wherein each substituent is independently halo, nitro, cyano, C1-C4 alkyl, C1-C4 alkoxy, halosubstituted C1-C4 alkyl, halosubstituted C1-C4 alkoxy, NR4R5, CO2R4 or CONR4R5, wherein R4 and R5 are each, independently, hydrogen or C1-C6 alkyl; Ar1 and Ar2 are each, independently, phenylene, mono-substituted phenylene or di-substituted phenylene, wherein the substituents are, independently, halo, C1-C4 alkyl, C1-C4 alkoxy, halo-substituted C1-C4 alkyl or halo-substituted C1-C4 alkoxy; X and X1 are each, independently, O, S, SO or SO2; R' is hydrogen or C1-C4 alkyl; and R2 and R3 are each, independently, methylene, ethylene or propylene. These compounds are useful for the treatment of disease states such as bronchial asthma, skin disorders and arthritis in mammals, and as the active ingredient in pharmaceutical compositions for treating such conditions.
Patent NZ-273047-A (NZ)
Title: Bolt assembly, with diagonally moving bolt for securing doors having a first bolt housing relatively movable with respect to a first bolt tip receiving means and a supplementary holding means
Inventor: KIBBLE ANTHONY WILFRED
IPC: E05B15/10
Filed: 1994-09-14
Abstract: PCT No. PCT/GB94/02001 Sec. 371 Date Mar. 8, 1996 Sec. 102(e) Date Mar. 8, 1996 PCT Filed Sep. 14, 1994 PCT Pub. No. WO95/08040 PCT Pub. Date Mar. 23, 1995This invention relates to a bolt housing, and in particular to a housing for a sliding bolt; to a pair of bolt housings, to an assembly thereof for the securement of a first housing relative to a second housing and to panels fitted with one of the said housings. Thus, there is provided a bolt housing which includes a bolt and bolt guide, the bolt having a bolt tip, the bolt being slidably mountable in the guide, the housing having a surface beyond which the bolt tip can project, the guide being at an acute angle to the said surface. There is also provided a bolt assembly comprising a bolt housing as defined herein, the said housing being a first housing, and the said bolt guide being a first bolt guide, the assembly including a second housing, the second housing having second bolt guide, the second bolt guide being alignable with first bolt guide, the bolt being movable into and out of the second bolt guide when the said first and second bolt guide are aligned. There is additionally provided a movable panel fitted with a first housing as defined herein, the panel being one of a sliding panel and a pivoting panel. The housings may be parts of a padlock.
Patent NZ-279979-A (NZ)
Title: Aerosolized formulation of mometasone furoate and it's use in treating airway passage and lung disease
Inventor: SEQUEIRA JOEL A
IPC: A61P11/02
Filed: 1995-01-26
Abstract: The use of mometasone furoate to treat a corticosteroid-responsive disease of the upper or lower airway passages or lungs.  The mometasone furoate composition is administered as a once-daily or twice-daily initial or maintenance medicament and results in a minimal amount of systemic absorption of mometasone furoate.  The composition is formulated to provide 25 -1000 micrograms of mometasone furoate per day and can be administered in the form of a dry powder, admixed with lactose or through a pressurized metered dose inhaler.
Patent NZ-306370-A (NZ)
Title: Method for the detection of viable cryptosporidium parvum oocysts
Inventor: VESEY GRAHAM
IPC: C12Q1/6893
Filed: 1996-05-06
Abstract: PCT No. PCT/AU96/00274 Sec. 371 Date Mar. 3, 1998 Sec. 102(e) Date Mar. 3, 1998 PCT Filed May 6, 1996 PCT Pub. No. WO96/34978 PCT Pub. Date Nov. 7, 1996Oligonucleotide molecules and methods are disclosed for the detection of viable oocysts or other cells of the protozoa species, Cyrptosporidium parvum. Preferred oligonucleotide molecules are selected from the group comprising oligonucleotides having one or more of the following sequences: (a) ACA ATT ATT, (b) CTT TTT GGT, (c) ATT TTA TAT AAA ATA TTT TGA TGA A, (d) TTT TTT TTT TTA GTA T, (e) TAT ATT TTT TAT CTG, (f) CTT TAC TTA CAT GGA TAA CCG, or comprising a part of the sequences (a) to (f) above so as to allow specific hybridization to unique 18S rRNA sequences of C. parvum.
Patent NZ-312834-A (NZ)
Title: Pasteurizable plastic container with sidewall panels flexing outwardly and inwardly to relieve positive and negative pressures
Inventor: KRISHNAKUMAR SUPPAYAN M
IPC: B65D1/02
Filed: 1996-07-17
Abstract: A pasteurizable plastic container having movable panels to alleviate internal pressure changes during pasteurization in order to avoid uncontrolled permanent deformation of the container body. As molded, each panel has a shallow recessed central wall which during the increased temperature and pressurization of pasteurization, moves outwardly to alleviate at least part of the internal pressure. During cooling, the panels move back inwardly to alleviate at least part of the negative pressure. The container may further include hoop ribs in the land areas above and below the panels, an axially elongatable hoop rib in an upper shoulder section, and an angled heel portion adjacent the standing ring. These additional elements further restrict uncontrolled bulging of the post walls, which would lead to improper label application and/or excessive volume change.
Patent NZ-329111-A (NZ)
Title: Two ply valved bag, inner ply forms valved pouch
Inventor: THOMPSON RAYMOND WALTER
IPC: B65D30/26
Filed: 1998-11-05
Abstract: A multi ply bag includes outer ply 12 (shown in an unfolded state) and inner ply 8 made of heat sealable material.  The plies are folded to form a bag in which the inner ply 8 forms a pouch closed at one end.  A valve 7 is inserted into the open end of the pouch to form a valve inlet which can be heat sealed.
Patent NZ-331379-A (NZ)
Title: Non-aqueous controlled release pest and air care gel composition
Inventor: MORRISON DAVID S
IPC: C09K3/00
Filed: 1997-02-21
Abstract: These controlled release non-aqueous air care gels comprise from 1 to 50 %weight basis of diblock, triblock, multiblock and/or radial block copolymers based on synthetic thermoplastic rubbers. The ratio of the diblock to triblock, multiblock and/or radial block copolymers can be varied from 0 percent to 100 percent in either direction. The material to be gelled is hydrocarbon, one or more hydrocarbon-soluble substances, or mixtures thereof, which based on its physical properties plays an important role in setting the controlled release rate. The composition of the hydrocarbon can vary in carbon length from C5 to C30 and can vary in vapor pressure up to 600 mm Hg at 20 °C. The hydrocarbon range on a weight basis is from about 20 to about 95 percent of the total weight of the gelled composition. The controlled release agent or active agent is one or more air care active substances, such as fragrances, deodorizers, masking agents, pest repellents or pesticides, and may comprise from about 0.1 to about 30 weight percent of the gel.
Patent NZ-335391-A (NZ)
Title: Container for dispersing material includes a housing and metering means enclosed at least partially within the housing
Inventor: WOODRUFF KEITH FLOYD
IPC: A01C7/02
Filed: 1999-04-26
Abstract: Methods and apparatus are provided for dispensing chemical material, and in particular, granular, agricultural material, from a moving device driven over terrain to be treated with the material. A metering system for dispersing the material includes on apertured metering disk positioned above a rotatable impeller. The apertured disk meters material from a product container, by gravity feed, onto the impeller below at a rate proportional to the linear speed at which the apparatus is driven to dispense material at a uniform density over the terrain. The metering disk is a component of a product container which is removably mounted to the device. The impeller rotates at a constant speed to disperse the deposited material at a uniform distance from the apparatus, and the position on which the material is deposited on the impeller is adjustable. A clutch permits the user to discontinue dispensing material from the device at the selection of the user, and automatically discontinues dispensing of material when the apparatus is driven in a reverse direction.
Patent NZ-500828-A (NZ)
Title: Preparation of reduced fat culinary sauce
Inventor: HARDMAN JANE
IPC: A23L33/20
Filed: 1998-04-20
Abstract: A process for the production of a reduced fat culinary sauce comprises mixing the ingredients of a reduced fat culinary sauce in which 10 to 50% by weight of the fat present in a regular culinary sauce is substituted by water, controlling the water activity to a value less than 0.95, mixing or precooking below 71 degrees C and then processing for a minimum of 0.87 minutes by continuous steam injection and holding at a temperature of at least 71 degrees C.
Patent NZ-503392-A (NZ)
Title: Transformation of  web browser interface by downloaded agent program
Inventor: HARRIS CHRISTOPHER JOHN
IPC: G06F9/445
Filed: 2000-03-14
Abstract: An agent program resident on a user computer can be updated with data from a server for the configuration of a browser program.  The agent program activates the browser program and configures the browser program to provide a particular graphical user interface when the browser is used to communicate with particular web sites.
Patent NZ-506695-A (NZ)
Title: Utilization of cd137 in order to promote the profileration of peripheral monocytes
Inventor: SCHWARZ HERBERT
IPC: A61K38/17
Filed: 1999-03-05
Abstract: Methods for preparing a dried cold-soluble milk protein concentrate (MPC) or milk protein isolate (MPI). The methods generally involve: a) Providing an MPI or MPC having at least 70% dry matter as milk protein in aqueous solution/suspension. b) Adding at least one monovalent salt in an amount that confers enhanced solubility on the product when dried; and c) Drying the product Wherein the amount of cation added is 0.013-0.30 moles of cation per 100g protein. An additional step may be added after step a) that involves removing part of the water from the MPC or MPI. Variations on the method are also disclosed, these include beginning with a skim milk solution, adding at least one monvalent salt to this and then concentrating the solution by ultrafiltration, optionally with diafiltration to form an MPI or MPC having at least 70% dry weight as protein and drying to prepare a dried product with enhanced solubility. The MPC and MPI is useful in chesse manufacture.
Patent NZ-507854-A (NZ)
Title: Flowering locus T (FT) and genetically modified plants having modulated flower development
Inventor: WEIGEL DETLEF
IPC: C12N15/29
Filed: 1999-04-13
Abstract: A genetically modified plant comprising at least one exogenous FT encoding nucleotide sequence in its genome, wherein the exogenous FT encoding nucleotide sequence has at least 80% sequence homology to SEQ ID NOS:1 is disclosed. The disclosure also provides a gene, termed "FT" for flowering locus T, and a polypeptide encoded by FT that modulates flower development in plants.  FT is useful in methods of the invention for producing genetically modified plants characterized as having the phenotypic trait of modulated flower development, for example early or delayed flowering.  Such plants can be genetically modified by nucleic acids encoding functional FT peptides; at least one antisense nucleic acid for FT; a structural gene that encodes wild-type FT polypeptide; or a structural gene that encodes dominant negative polypeptides, for example, in order to modulate flowering in the plant.
Patent NZ-508903-A (NZ)
Title: Gas jet stripping baffle
Inventor: TU CAT
IPC: B05C11/06
Filed: 1999-05-25
Abstract: A flow diversion device for use in a gas jet stripping apparatus includes a baffle (26) having a first portion (17) which in use extends longitudinally of the moving strip (4) which is being subjected to the stripping action of the jet stripping nozzles of the gas jet stripping apparatus. The baffle further includes a second portion (19) which diverges away from the moving strip (4) and a gas outlet (27) for providing gas to the strip side of the baffle (26). The baffle is characterised by a gas collection means (20) for redirecting gas from the stripping nozzles to the gas outlet (27). An auxiliary gas supply may be provided to supplement the gas exiting gas outlet (27) to ensure the correct operation of the flow diversion device.
Patent NZ-512504-A (NZ)
Title: Method for separating viral particles
Inventor: BLANCHE FRANCIS
IPC: C12N7/01
Filed: 1999-12-30
Abstract: Disclosed is a method for purifying and quantifying viral particles from a biological medium, particularly, adenovirus by ion-exchange chromatography. The method comprises contacting the biological medium with a support comprising a cross-linked agarose matrix and ion exchange groups bound to the said matrix by a flexible arm, such that the contact between the biological medium and the support chromatographically separates the virus particles from the biological medium. Also disclosed is a method for identifying different adenovirus serotypes.
Patent NZ-514826-A (NZ)
Title: Medicinal product for the treatment of diabetes
Inventor: SANDER-STRUCKMEIER SUNTJE
IPC: A61K38/46
Filed: 2000-03-15
Abstract: The use of physiologically acceptable enzyme mixtures with lipolytic, proteolytic and amylolytic activity in the manufacture of medicaments for the treatment of type I primary diabetes mellitus in larger mammals or humans.
Patent NZ-515933-A (NZ)
Title: Ceruloplasmin and composition comprising pyruvate, lipid and an antioxidant (vitamin E)
Inventor: PAQUIN JOANNE
IPC: A61K38/43
Filed: 2000-05-05
Abstract: A neuroprotective composition comprises ceruloplasmin or a functional derivative thereof and a neutralizing antioxidant having the capacity of neutralizing potential negative effects of H2O2 on the ceruloplasmin. The ceruloplasmin and neutralizing antioxidant are present in an amount to have a synergistic therapeutically effective beneficial effect on neuronal cells. Preferably the antioxidant is vitamin E. The composition may further comprise pyruvate. The composition can be use din the manufacture of a medicament for the treatment of neuronal cells, brain trauma, amyotrophic lateral sclerosis, neurodegenerative diseases or poisoning of neuronal cells, the diminution of drugs side effects or the preservation of neuronal grafts. Also described is the use of ceruplasmin or a functional derivative thereof as an active agent in the preparation of a medicament for protecting neuronal cells against an oxidative stress or for treating neuronal oxidative stress related condition with the proviso that the composition does not comprises GP1-CP as the active agent.
Patent NZ-519566-A (NZ)
Title: 3-Substituted 4-phenyl-piperazine or piperidine derivatives useful as modulators of dopamine neurotransmission
Inventor: SONESSON CLAS
IPC: A61P25/06
Filed: 2000-12-22
Abstract: Substituted 4-(phenyl-N-alkyl)-piperazine or 4-(phenyl-N-alkyl)-piperidine compounds of formula (I), wherein; X is N, CH, or C, however X may only be C when the compound comprises a double bond at the dotted line; R1 is CF3, OSO2CF3, OSO2CH3, SOR7, SO2R7, COR7, CN, OR3, NO2, CONHR3, 3-thiophene, 2-thiophene, 3-furane, 2-furane, F, Cl, Br, or I; R2 is F, Cl, Br, I, CN, CF3, CH3, OCH3, OH, and NH2; R3 is H or a C1-C4 alkyl; R4 is a C1-C4 alkyl R5 is a C1-C4 alkyl, an allyl, CH2SCH3, CH2CH2OCH3, CH2CH2CH2F, CH2CF3, 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, or -(CH2)-R6; R6 is a C3-C6 cycloalkyl, 2-tetrahydrofurane, or 3-tetrahydrofurane; R7 is a C1-C3 alkyl, CF3, or N(R4)2, and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising the above compounds and methods wherein the above compounds are used for treatment of disorders in the central nervous system are also disclosed.
Patent NZ-520805-A (NZ)
Title: Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
Inventor: CASARA PATRICK
IPC: A61K31/44
Filed: 2001-03-06
Abstract: A bicyclic compound of formula (I); the preparation thereof; and use of the compound as vitronectin receptor antagonists is disclosed, wherein the variables are as defined in the specification.